Image de couverture de livre

National survey of urologists' views on prostate cancer screening in the United Kingdom

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nikhil Mayor, Francesca Rawlins, Emma Cullen, Varsha Sonigra‐Patel, Rhian Gabe, Hashim U. Ahmed
Format:	Artículo Open Access
Publié:	Wiley 2026
Sujets:	BJUI Compass
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
par: Nadia Rokan, et autres
Publié: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

The impact of pre‐biopsy MRI and additional testing on prostate cancer screening outcomes: A rapid review
par: Abel Tesfai, et autres
Publié: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
par: Eric V. Li, et autres
Publié: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
par: Eric Margolis, et autres
Publié: (2025)

Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)

Effect of prior HoLEP procedure on multiparametric MRI accuracy in detection of prostate cancer
par: Austin Drysch, et autres
Publié: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
par: Sophia M. Abusamra, et autres
Publié: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
par: Esther H. J. Hamoen, et autres
Publié: (2025)

Concordance of renal tumour assessments by urologists using CT scans versus Hyper‐Accuracy 3D Virtual Models for surgical planning: A single‐centre multireviewer analysis
par: Francesco Ditonno, et autres
Publié: (2025)

Bibliometric analysis of focal therapy in prostate cancer research
par: Mohammed Shahait, et autres
Publié: (2024)

PSMA PET/CT findings in high‐risk biochemical recurrence after local treatment of prostate cancer
par: Nicole Handa, et autres
Publié: (2025)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
par: Ailene E. Corona, et autres
Publié: (2026)

Urology never events in the United Kingdom: A retrospective 10‐year review
par: Jerocin Vishani Loyala, et autres
Publié: (2024)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
par: Ruth Pidsley, et autres
Publié: (2024)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
par: Angelo Porreca, et autres
Publié: (2025)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
par: Geneva Pantoja, et autres
Publié: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
par: Sofia Mesquita, et autres
Publié: (2025)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
par: Ryan Sutherland, et autres
Publié: (2024)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
par: Samantha Shekar, et autres
Publié: (2025)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
par: Marcus Sondermann, et autres
Publié: (2025)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
par: Muhammad Imran, et autres
Publié: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
par: Sandra Irenaeus, et autres
Publié: (2025)

Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
par: Alan Priester, et autres
Publié: (2024)

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer
par: Jennifer Dunsmore, et autres
Publié: (2024)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
par: Herbert Lepor, et autres
Publié: (2025)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
par: Maxwell Louis Sandberg, et autres
Publié: (2026)

Association between beta‐blocker atenolol use and prostate cancer upgrading in active surveillance1
par: Ali H. Zahalka, et autres
Publié: (2024)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
par: See‐Tong Pang, et autres
Publié: (2025)

Clinical validation of a biopsy‐based six‐gene signature prognostic for aggressive prostate cancer
par: Agnieszka Krzyzanowska, et autres
Publié: (2024)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
par: Mathew Thakur, et autres
Publié: (2024)

Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
par: Lisa Browning, et autres
Publié: (2025)

Oncological outcomes post focal low‐dose‐rate brachytherapy in low‐intermediate risk prostate cancer
par: Mohammadmehdi Adhami, et autres
Publié: (2026)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
par: Kunal K. Sindhu, et autres
Publié: (2024)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
par: Stijn M. van den Bosch, et autres
Publié: (2026)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
par: Yuki Teramoto, et autres
Publié: (2026)

A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility
par: Lorenzo Storino Ramacciotti, et autres
Publié: (2024)